Skip to main content
. Author manuscript; available in PMC: 2022 Mar 30.
Published in final edited form as: Nat Ecol Evol. 2021 Apr 12;5(6):826–835. doi: 10.1038/s41559-021-01428-w

Extended Data Fig. 7 ∣. Constant dose treatments in a Gompertzian growth model (Model 3 in the main text).

Extended Data Fig. 7 ∣

Tumour size for various constant dose treatments are compared to containment at the initial size (subject to Cmax = 2), MTD (C = Cmax) and ideal MTD. Dose 1.09 maximizes time to progression and 0.74 maximizes survival time among non-delayed constant doses (but is inferior to the optimal delayed constant dose). Parameter values are as in Table 2 of the main text.